Skip to main content
Demetrios Vavvas, MD, Ophthalmology, Boston, MA

DemetriosVavvasMDPh.D.(He/Him)

Ophthalmology • Boston, MA

Retinal Disease

Solman and Libe Friedman Professor of Ophthalmology, Harvard Medical School Co-Director Ocular Regenerative Medical Institute Associate Director Retina Service MEEI Principal Investigator Angiogenesis Laboratory Mass. Eye and Ear Infirmary and Mass General Hospital

Join to view full profile

Dr. Vavvas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Vavvas' full profile

Already have an account?

  • Office

    243 Charles St
    Boston, MA 02114
    Phone+1 617-573-5589

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolChief Residency, Ophthalmology, 2003 - 2004
  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2000 - 2004
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1999 - 2000
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1999
  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous
  • McGill University
    McGill UniversityB.Sc., Biology/ Neuroscience, First Class Honors

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2026
  • American Board of Ophthalmology Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Permanent Neuroglial Remodeling of the Retina Following Infiltration of CSF1R Inhibition-Resistant Peripheral Monocytes  
    Claes H Dohlman, James Chodosh, Demetrios G Vavvas, Reza Dana, Proceedings of the National Academy of Sciences

Press Mentions

  • Apellis’ Syfovre Approved as First Treatment for Geographic Atrophy Despite Uncertain Clinical Benefit
    Apellis’ Syfovre Approved as First Treatment for Geographic Atrophy Despite Uncertain Clinical BenefitMarch 7th, 2023
  • Apellis Wins FDA Approval of First Drug for Type of Vision Loss
    Apellis Wins FDA Approval of First Drug for Type of Vision LossFebruary 17th, 2023
  • RETINA CONVERSATIONS: A Conversation with Evangelos S. Gragoudas, MD
    RETINA CONVERSATIONS: A Conversation with Evangelos S. Gragoudas, MDMarch 1st, 2019
  • Join now to see all

Dr. Demetrios Vavvas, Dr. Demetrios Vavvas, MD, Dr. D Vavvas